Back to today’s briefing

Story perspectives

Revolutionary Weight-Loss Pills Outshine Popular Injectables

6/22/2025

50 8

Summary

Story summary

A groundbreaking weight-loss drug, Amycretin, is making waves in early trials, surpassing popular GLP-1 medications like Wegovy and Mounjaro. This innovative tablet offers a convenient, non-injectable alternative. Additionally, Eli Lilly's orforglipron pill is showing promising results in weight loss and blood sugar management, with regulatory approval on the horizon.

1 of 1

Story summary

A groundbreaking weight-loss drug, Amycretin, is making waves in early trials, surpassing popular GLP-1 medications like Wegovy and Mounjaro. This innovative tablet offers a convenient, non-injectable alternative. Additionally, Eli Lilly's orforglipron pill is showing promising results in weight loss and blood sugar management, with regulatory approval on the horizon.